Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2015

01.05.2015 | General Gynecology

RETRACTED ARTICLE: Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome

verfasst von: Xiao-Hong Wang, Jun-Qing Wang, Yan Xu, Li-Ping Huang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare the therapeutic effects of metformin (Met) and laparoscopic ovarian drilling (LOD) in clomiphene and insulin-resistant patients with polycystic ovary syndrome (CIRPCOS).

Methods

A total of 110 patients were randomly divided into two groups. One group was administered Met (n = 55), while the other group underwent LOD (n = 55). Rates of ovulation, pregnancy, and abortion were compared between both groups.

Results

Rates of normal menstruation, ovulation, and pregnancy in the LOD group were higher than in the Met group: 76.4 % (42/55) vs. 58.2 % (32/55), P < 0.04; 50.8 % (11/258) vs. 33.5 % (94/281), P < 0.001; 38.2 % (21/55) vs. 20.0 % (11/55), P < 0.03. The difference in the early abortion rate between both groups was not statistically significant.

Conclusions

Although Met can significantly improve a patient’s insulin resistance, we found that in patients diagnosed with CIRCPOS, LOD can be much more effective in improving rates of normal menstruation, ovulation, and pregnancy.
Literatur
1.
2.
Zurück zum Zitat Hart R, Norman R (2006) Polycystic ovarian syndrome-prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 20:251–278CrossRef Hart R, Norman R (2006) Polycystic ovarian syndrome-prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 20:251–278CrossRef
3.
Zurück zum Zitat Palomba S, Orio F, Zullo F (2006) Ovulation induction in women with polycystic ovary syndrome. Fetril Steril 86:26–27CrossRef Palomba S, Orio F, Zullo F (2006) Ovulation induction in women with polycystic ovary syndrome. Fetril Steril 86:26–27CrossRef
4.
Zurück zum Zitat Dabirashrafi H (1989) Complications of laparoscopic ovarian cauterization. Fertil Steril 52(5):878–879PubMed Dabirashrafi H (1989) Complications of laparoscopic ovarian cauterization. Fertil Steril 52(5):878–879PubMed
5.
Zurück zum Zitat Elsherbnyw, Alinanyh, Ibrahimm et al Antimullerian hormone as a predictor of ovarian reserve after laparoscopic ovarian drilling[C]. In: Abstracts of the 26th annual meeting of ESHRE, Rome, June 27–30 Elsherbnyw, Alinanyh, Ibrahimm et al Antimullerian hormone as a predictor of ovarian reserve after laparoscopic ovarian drilling[C]. In: Abstracts of the 26th annual meeting of ESHRE, Rome, June 27–30
6.
Zurück zum Zitat Kandilm Selimm (2005) Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome[J]. BJOG 112(10):1427–1430CrossRef Kandilm Selimm (2005) Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome[J]. BJOG 112(10):1427–1430CrossRef
7.
Zurück zum Zitat Api M (2009) Is ovarian reserve diminished after laparoscopic ovarian drilling?[J]. Gynecol Endocrinol 25(3):159–165CrossRefPubMed Api M (2009) Is ovarian reserve diminished after laparoscopic ovarian drilling?[J]. Gynecol Endocrinol 25(3):159–165CrossRefPubMed
8.
Zurück zum Zitat Lertvikools, Weerakiets, Ingthanatikuly et al (2007) Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling[J]. Gynecol Endocrinol 23(8):455–460CrossRef Lertvikools, Weerakiets, Ingthanatikuly et al (2007) Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling[J]. Gynecol Endocrinol 23(8):455–460CrossRef
9.
Zurück zum Zitat Seow KM, Juan CC, Hwang JL, Ho LT (2008) Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med 26:101–110CrossRefPubMed Seow KM, Juan CC, Hwang JL, Ho LT (2008) Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med 26:101–110CrossRefPubMed
10.
Zurück zum Zitat Lord JM, Flight IH, Norman RJ (2008) Insulin-sensitizing drugs (metformin, trogletazone, rosigliotazone, pioglitazone, D-chiro-inos-itol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3:CD003053 Lord JM, Flight IH, Norman RJ (2008) Insulin-sensitizing drugs (metformin, trogletazone, rosigliotazone, pioglitazone, D-chiro-inos-itol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3:CD003053
11.
Zurück zum Zitat Norman RJ (2004) Editorial: metformin-comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89:4797–4800CrossRefPubMed Norman RJ (2004) Editorial: metformin-comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89:4797–4800CrossRefPubMed
12.
Zurück zum Zitat De Leo V, La Marca A, Petraglia F (2003) Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 24:633–667CrossRefPubMed De Leo V, La Marca A, Petraglia F (2003) Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 24:633–667CrossRefPubMed
13.
Zurück zum Zitat Malkawi HY, Qublan HS, Hamaideh AH (2003) Medical vs surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome. J Obstet Gynaecol 23:289–293CrossRefPubMed Malkawi HY, Qublan HS, Hamaideh AH (2003) Medical vs surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome. J Obstet Gynaecol 23:289–293CrossRefPubMed
14.
Zurück zum Zitat Palomba S, Orio F Jr, Nardo LG et al (2004) Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 89:4801–4809CrossRefPubMed Palomba S, Orio F Jr, Nardo LG et al (2004) Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 89:4801–4809CrossRefPubMed
15.
Zurück zum Zitat Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
16.
Zurück zum Zitat Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ (2007) Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril 87:213–217CrossRef Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ (2007) Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril 87:213–217CrossRef
17.
Zurück zum Zitat Tulandi T, Saleh A, Morris D, Jacobs HS, Payne NN, Tan SL (2000) Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to oral glucose tolerance test in women with polycystic ovarian syndrome. Fertil Steril 74:585–588CrossRefPubMed Tulandi T, Saleh A, Morris D, Jacobs HS, Payne NN, Tan SL (2000) Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to oral glucose tolerance test in women with polycystic ovarian syndrome. Fertil Steril 74:585–588CrossRefPubMed
18.
Zurück zum Zitat Gabir MM, Haanson RL, Dabelea D et al (2000) The 1997 American diabetes association and 1999 world health organization criteria for hyperglycemia in the diagnosis and prediction of diabetaes[J]. Diabetes Care 23(8):1108–1112CrossRefPubMed Gabir MM, Haanson RL, Dabelea D et al (2000) The 1997 American diabetes association and 1999 world health organization criteria for hyperglycemia in the diagnosis and prediction of diabetaes[J]. Diabetes Care 23(8):1108–1112CrossRefPubMed
19.
Zurück zum Zitat Tang T, Glanville J, Hayden CJ (2000) Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized placebo-controlled double blind multicenter study. Hum Reprod 21:80–89CrossRef Tang T, Glanville J, Hayden CJ (2000) Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized placebo-controlled double blind multicenter study. Hum Reprod 21:80–89CrossRef
20.
Zurück zum Zitat Tan S, Hahn S, Benson S et al (2007) Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 157:669–676CrossRefPubMed Tan S, Hahn S, Benson S et al (2007) Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 157:669–676CrossRefPubMed
21.
Zurück zum Zitat Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068–4074CrossRefPubMed Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068–4074CrossRefPubMed
22.
Zurück zum Zitat Pirwany IR, Tulandi T (2003) Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure. Fertil Steril 80:241–251CrossRefPubMed Pirwany IR, Tulandi T (2003) Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure. Fertil Steril 80:241–251CrossRefPubMed
23.
Zurück zum Zitat Pirwany IR, Yates RW, Cameron IT, Fleming R (1999) Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea. Hum Reprod 14:2963–2968CrossRefPubMed Pirwany IR, Yates RW, Cameron IT, Fleming R (1999) Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea. Hum Reprod 14:2963–2968CrossRefPubMed
24.
Zurück zum Zitat Youssef H, Atallah MM (2007) Unilateral ovarian drilling in polycystic ovary syndrome: a prospective randomized study. Reprod Biomed Online 15:457–462CrossRefPubMed Youssef H, Atallah MM (2007) Unilateral ovarian drilling in polycystic ovary syndrome: a prospective randomized study. Reprod Biomed Online 15:457–462CrossRefPubMed
25.
Zurück zum Zitat Farquhar CM (2004) The role of ovarian surgery in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:789–802CrossRefPubMed Farquhar CM (2004) The role of ovarian surgery in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:789–802CrossRefPubMed
26.
Zurück zum Zitat Saleh A, Morris D, Tan SL, Tulandi T (2001) Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia. Fertil Steril 75:501–504CrossRefPubMed Saleh A, Morris D, Tan SL, Tulandi T (2001) Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia. Fertil Steril 75:501–504CrossRefPubMed
27.
Zurück zum Zitat Api M, Gorgen H, Cetin A (2005) Laparoscopic ovarian drilling in polycystic ovary syndrome. Eur J Obstet Gynaecol Reprod Biol 119:76–81CrossRef Api M, Gorgen H, Cetin A (2005) Laparoscopic ovarian drilling in polycystic ovary syndrome. Eur J Obstet Gynaecol Reprod Biol 119:76–81CrossRef
28.
Zurück zum Zitat Farquhar C, Brown J, Marjoribanks J (2012) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome[J]. Cochrane Database Syst Rev 6:CD001122PubMed Farquhar C, Brown J, Marjoribanks J (2012) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome[J]. Cochrane Database Syst Rev 6:CD001122PubMed
29.
Zurück zum Zitat Legro RS, Barnhart HX, Schlaff WD et al (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551–566CrossRefPubMed Legro RS, Barnhart HX, Schlaff WD et al (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551–566CrossRefPubMed
Metadaten
Titel
RETRACTED ARTICLE: Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome
verfasst von
Xiao-Hong Wang
Jun-Qing Wang
Yan Xu
Li-Ping Huang
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3486-z

Weitere Artikel der Ausgabe 5/2015

Archives of Gynecology and Obstetrics 5/2015 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.